Dyslipidaemia among black patients with type 2 diabetes

Cardiovascular Journal of South Africa

Volumn 16, Issue 4, 2005, Pages 194-198

  Vezi, Z B ^a,b   Naidoo, D P ^a  

^a INKOSI ALBERT LUTHULI CENTRAL HOSPITAL   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; SOUTH AFRICA; TRIGLYCERIDES;

EID: 28244435910     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. SEMDASA consensus document: S Afr Med J 1997; 87: 497-512.
2. Isomaa B, Lahti K, Almgren P, Nissen M. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabet Care 2001; 24: 683-689.
3. Laakso M, Lehto S, Penttila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin dependant diabetes. Circulation 1993; 88: 1421-1430.
4. Folsom AR, Nieto FJ, McGovern PG. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Diabet care 1997; 20: 935-942.
5. Albrink MJ, Meigs JW, Man EB. Serum lipids, hypertension and coronary artery disease. Am J Med 1961; 31: 4-23.
6. Ginsburg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106: 453-458.
7. Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003; 52: 172-179.
8. Haffner SM. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol 2002; 90: 55i-61i.
9. Haffner SM. Management of dyslipidaemia in adults with diabetes. Diabet Care 1998; 21: 160-178.
10. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidaemia and diabetes mellitus. Mayo Clin Proc 1998; 73: 969-976.
11. Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, et al. The pattern of dyslipidaemia among African-Americans with type 2 Diabetes. Diabet Care 2000; 23(3): 319-324.
12. Massing MW, Henley NS, Carter-Edwards L, et al. Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabet Care 2003; 26(5): 1369-1373.
13. Keil JE, Sutherland SE, Knapp RG. Mortality rates and risks factors for coronary disease in black as compared with white men and women. New Engl J Med 1993; 329(2): 73-78.
14. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. WHO and NDDG. Diabet Med 1997; 15: 539-553.
15. Excutive summary of the third report of the National Cholesterol Education Program (NCEP). Adult Panel III. J Am Med Assoc 2001; 285: 2486-2497.
16. Mogansen CE. Microalbuminuria and hypertension with focus on type 1 and 2 diabetes. J Intern Med 2003; 254: 45-66.
17. Marais AD, Berger GMB. A diversity of genetic hyperlipoproteinaemias in black patients. S Afr Med J 1986; 70: 583-587.
18. Marais AD, Berger G.M. Fatal outcome of homozygous familial hypercholesterolaemia in a black patient. S Afr Med J 1990; 77: 588-590.
19. Ogilvie A. Disparate prevalences of small dense LDL particles in male and female black diabetic subjects. Abstr LASSA symposium, Durban.
20. Mayosi BM. The lipid profile of black Africans with acute coronary syndromes: a case control study. 4th International Symposium on Multiple Risk Factors in Cardiovascular Disease, Washington April 1997.
21. Marais AD. Dyslipidaemia in diabetes mellitus. Spec Med 2000; 22: 148-179.
22. Walden CE Walden CE, Knopp RH, Wahl PW, Beach KW, et al. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. New Engl J Med 1984; 311: 953-959.
23. Siegel RD, Cupples A, Schaefer EJ, Wilson PW. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham Offspring Study. Metabolism 1996; 45: 1267-1272.
24. Knopp RH, Broyles FE, Bonet B, Walden CE. Exaggerated lipoprotein abnormalities in diabetic women compared to diabetic men. Cardiovascular Health and Disease in Women: LeJaq Communications 1993: 131-138.
25. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. New Engl J Med 1998; 339: 229-234.
26. Scandinavian Simvastatin Survival Study Group (4S). Randomized clinical trial of cholesterol lowering in 4444 patients with coronary artery disease. Lancet 1994; 344: 1383-1389.
27. Sacks FM, Pfeffer MA, Moye LA, et al. (CARE) Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
28. Shepherd J, Cobbe Stuart M, Ford I, et al. (WOSCOPS) Prevention of coronary artery disease with Pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.
29. Gotto AM (Jr). (AFCAPS/TexCAPS) AHA 70th Scientific Sessions: Nov 12, 1997; Orlando, Florida.
30. Tonkin A. (LIPID) AHA 70th Scientific Sessions: Nov 12. 1997; Orlando, Forida.
31. Heart Protection Study Collaborative Group using simvastatin in high-risk individuals. Lancet 2002; 360: 7-22.
32. Gordon DJ, Probstfield JL, Garrison RJ, et al. High density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8-15.
33. Rubins HB, Robins SJ, Collins D, Fye CL, et al for VA-HIT Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of HDL-C. N Engl J Med 1999; 341: 410-418.
34. Wilson PW, Anderson KM, Kannel W, et al. Epidemiology of diabetes mellitus in the elderly. The Framingham study. Am J Med 1986; 80(5A): 3-9.
35. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African-Americans and whites with non-insulin dependant diabetes in the US population. Circulation 1994; 90: 1185-1193.
36. Miller M, Seidler A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events. J Am Coll Cardiol 1998; 31: 1252-1257.
37. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level. J Cardiovasc Risk 1996; 3: 213-219.
38. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B.
39. Rosenstock J, Raskin P. Hypertension in diabetes mellitus. Cardiol Clin 1988; 6: 547-560.
40. Simonson DC. Aetiology and prevalence of hypertension in diabetic patients. Diabet Care 1988; 11: 821-827.
41. Adler AI, Stratton IM, Neil HA, Yudkin JS, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes: UKPDS 36. Br Med J 2000; 321: 412-419.
42. Ritz E. Albuminuria and vascular damage - the viscious twins. N Engl J Med 2003; 348: 2349-2352.
43. Stratton IM, Adler AI, Neil AW. Association of hyperglycaemia with microvascular and macrovascular complications of type 2 diabetes (UKPDS 35). Br Med J 2000; 321: 405-412.
44. Spoelstra-de Man AME, Brouwer CB, Stehouwer CDA, et al. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabet Care 2001; 24: 2097-2101.
45. Adler AI, Stevens RJ, Manley SE, et al. development and progression of nephropathy in type 2 diabetes: observations and modeling from UKPDS. Kidney Int 2003; 63: 225-232.
46. Seftel HC, Keeley KJ, Walker ARP. Characteristics of South African Bantu who have suffered from myocardial infarct. Am J Cardiol 1963; 12: 148.
47. Seftel HC, Keeley KJ. The rarity of coronary heart disease in South African blacks. S Afr Med J 1978; 54: 99.
48. Seedat YK, Mayet FGH, Latiff GH, et al. Risk factors and coronary heart disease in Durban blacks the missing links. S Afr Med J 1992; 82: 251-256.
49. Grundy Scott M, Balady Gary J, Criqui Michael H, et al. When to start cholesterol-lowering therapy in patients with coronary heart disease: A statement for healthcare professionals from the American Heart Association task force on risk reduction. Circulation 1997; 95: 1683-1685.
50. Joslin EP. Arteriosclerosis and diabetes. Ann Clin Med 1927; 5: 1061.